A Phase I, Two-Part, Randomised, Open, Single-Centre, Crossover Study to Evaluate Different Extended-Release Formulations of AZD1305 When Given as Single Oral Doses to Healthy Male Volunteers.

Trial Profile

A Phase I, Two-Part, Randomised, Open, Single-Centre, Crossover Study to Evaluate Different Extended-Release Formulations of AZD1305 When Given as Single Oral Doses to Healthy Male Volunteers.

Completed
Phase of Trial: Phase I

Latest Information Update: 02 Dec 2010

At a glance

  • Drugs AZD 1305 (Primary)
  • Indications Arrhythmias
  • Focus Pharmacokinetics
  • Most Recent Events

    • 02 Dec 2010 Actual end date (Jul 2008) added as reported by ClinicalTrials.gov.
    • 23 Jan 2009 Status changed from recruiting to completed as reported by ClinicalTrials.gov.
    • 27 Jun 2008 New trial record.
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top